Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.91 SEK 1.67% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Vicore Pharma Holding AB
Other Non-Cash Items

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vicore Pharma Holding AB
Other Non-Cash Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Non-Cash Items CAGR 3Y CAGR 5Y CAGR 10Y
Vicore Pharma Holding AB
STO:VICO
Other Non-Cash Items
kr75.8m
CAGR 3-Years
123%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biogaia AB
STO:BIOG B
Other Non-Cash Items
-kr1.5m
CAGR 3-Years
26%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bonesupport Holding AB
STO:BONEX
Other Non-Cash Items
kr61.5m
CAGR 3-Years
69%
CAGR 5-Years
40%
CAGR 10-Years
N/A
Vitrolife AB
STO:VITR
Other Non-Cash Items
kr4.8B
CAGR 3-Years
282%
CAGR 5-Years
125%
CAGR 10-Years
68%
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
Other Non-Cash Items
kr1.9B
CAGR 3-Years
45%
CAGR 5-Years
N/A
CAGR 10-Years
25%
BioArctic AB
STO:BIOA B
Other Non-Cash Items
kr2.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Vicore Pharma Holding AB
Glance View

Market Cap
1.9B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
2.94 SEK
Overvaluation 63%
Intrinsic Value
Price

See Also

What is Vicore Pharma Holding AB's Other Non-Cash Items?
Other Non-Cash Items
75.8m SEK

Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Other Non-Cash Items amounts to 75.8m SEK.

What is Vicore Pharma Holding AB's Other Non-Cash Items growth rate?
Other Non-Cash Items CAGR 3Y
123%

Over the last year, the Other Non-Cash Items growth was 890%. The average annual Other Non-Cash Items growth rates for Vicore Pharma Holding AB have been 123% over the past three years .

Back to Top